{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:35:30Z","timestamp":1775709330480,"version":"3.50.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12026-025-09592-y","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T20:43:11Z","timestamp":1736973791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between TLR 2 (rs3804099), TLR4 (rs4986790), and TLR 9 (rs187084) polymorphism and leukemia risk: a systematic review\u00a0and meta-analysis"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7337-3356","authenticated-orcid":false,"given":"Rupesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anindita","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayur Mausoom","family":"Phukan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"issue":"3","key":"9592_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"13","key":"9592_CR2","doi-asserted-by":"publisher","first-page":"e33754","DOI":"10.1016\/j.heliyon.2024.e33754","volume":"10","author":"FM Alkhulaifi","year":"2024","unstructured":"Alkhulaifi FM, Alonaizan R, Rady A, Alomar S. Study of gene polymorphisms in Toll-like receptor 2 in patients with acute lymphoblastic leukemia. Heliyon. 2024;10(13):e33754.","journal-title":"Heliyon"},{"issue":"1","key":"9592_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13690-023-01154-8","volume":"81","author":"M Amini","year":"2023","unstructured":"Amini M, Sharma R, Jani C. Gender differences in leukemia outcomes based on health care expenditures using estimates from the GLOBOCAN 2020. Arch Public Health. 2023;81(1):151.","journal-title":"Arch Public Health"},{"issue":"1","key":"9592_CR4","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/S2352-3026(17)30232-6","volume":"5","author":"A Miranda-Filho","year":"2018","unstructured":"Miranda-Filho A, Pi\u00f1eros M, Ferlay J, Soerjomataram I, Monnereau A, Bray F. Epidemiological patterns of leukaemia in 184 countries: a population-based study. Lancet Haematol. 2018;5(1):e14\u201324.","journal-title":"Lancet Haematol"},{"issue":"7","key":"9592_CR5","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/imj.16445","volume":"54","author":"D Baggio","year":"2024","unstructured":"Baggio D, Chung E, Wellard C, et al. Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern era. Intern Med J. 2024;54(7):1223\u20137.","journal-title":"Intern Med J"},{"issue":"6","key":"9592_CR6","doi-asserted-by":"publisher","first-page":"a034819","DOI":"10.1101\/cshperspect.a034819","volume":"10","author":"JAB Bispo","year":"2020","unstructured":"Bispo JAB, Pinheiro PS, Kobetz EK. Epidemiology and etiology of leukemia and lymphoma. Cold Spring Harb Perspect Med. 2020;10(6):a034819.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"9592_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.17816\/KMJ625488","volume":"105","author":"SK Pinaev","year":"2024","unstructured":"Pinaev SK, Starinsky VV, Chizhov AY, Pinaeva OG. Comparative analysis of the relationship between leukemia trends with forest fires and solar activity in different age groups. Kazan Med J. 2024;105(3):433\u201342.","journal-title":"Kazan Med J"},{"issue":"1","key":"9592_CR8","doi-asserted-by":"publisher","first-page":"2329024","DOI":"10.1080\/16078454.2024.2329024","volume":"29","author":"M Alqahtani","year":"2024","unstructured":"Alqahtani M, Aljuaimlani A, Al-Tamimi J, Alomar S, Mansour L. TIM3 and CTLA4 immune checkpoint polymorphisms are associated with acute myeloid leukemia in Saudi Arabia. Hematology. 2024;29(1):2329024.","journal-title":"Hematology"},{"issue":"2","key":"9592_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41568-020-00315-z","volume":"21","author":"JM Klco","year":"2021","unstructured":"Klco JM, Mullighan CG. Advances in germline predisposition to acute leukaemias and myeloid neoplasms. Nat Rev Cancer. 2021;21(2):122\u201337.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"9592_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.exphem.2014.11.003","volume":"43","author":"KK Thakur","year":"2015","unstructured":"Thakur KK, Bolshette NB, Trandafir C, Jamdade VS, Istrate A, Gogoi R, Cucuianu A. Role of toll-like receptors in multiple myeloma and recent advances. Exp Hematol. 2015;43(3):158\u201367.","journal-title":"Exp Hematol"},{"issue":"2","key":"9592_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/cancers12020297","volume":"12","author":"N Javaid","year":"2020","unstructured":"Javaid N, Choi S. Toll-like receptors from the perspective of cancer treatment. Cancers (Basel). 2020;12(2):297.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"9592_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2009.08.010","volume":"49","author":"X Li","year":"2010","unstructured":"Li X, Jiang S, Tapping RI. Toll-like receptor signaling in cell proliferation and survival. Cytokine. 2010;49(1):1\u20139.","journal-title":"Cytokine"},{"issue":"4","key":"9592_CR13","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/pro.4043","volume":"30","author":"J Asami","year":"2021","unstructured":"Asami J, Shimizu T. Structural and functional understanding of the toll-like receptors. Protein Sci. 2021;30(4):761\u201372.","journal-title":"Protein Sci"},{"issue":"3","key":"9592_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tibs.2011.11.003","volume":"37","author":"M Gangloff","year":"2012","unstructured":"Gangloff M. Different dimerisation mode for TLR4 upon endosomal acidification? Trends Biochem Sci. 2012;37(3):92\u20138.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"9592_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s12307-008-0005-4","volume":"1","author":"J Zeromski","year":"2008","unstructured":"Zeromski J, Mozer-Lisewska I, Kaczmarek M. Significance of toll-like receptors expression in tumor growth and spreading: a short review. Cancer Microenviron. 2008;1(1):37\u201342.","journal-title":"Cancer Microenviron"},{"issue":"4","key":"9592_CR16","first-page":"303","volume":"12","author":"M Ramzi","year":"2018","unstructured":"Ramzi M, Khalafi-Nezhad A, IravaniSaadi M, Jowkar Z. Association between TLR2 and TLR4 expression and response to induction therapy in acute myeloid leukemia patients. Int J Hematol Oncol Stem Cell Res. 2018;12(4):303\u201312.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"9592_CR17","doi-asserted-by":"publisher","first-page":"e930438","DOI":"10.12659\/MSM.930438","volume":"27","author":"M Sun","year":"2021","unstructured":"Sun M, Jiang H, Meng T, Liu P, Chen H. Association between TLR4 gene polymorphisms and risk of preeclampsia: systematic review and meta-analysis. Med Sci Monit. 2021;27:e930438.","journal-title":"Med Sci Monit"},{"issue":"12","key":"9592_CR18","doi-asserted-by":"publisher","first-page":"798001","DOI":"10.3389\/fgene.2021.798001","volume":"21","author":"S Fei","year":"2022","unstructured":"Fei S, Gui Z, Feng D, Wang Z, Zheng M, Chen H, Sun L, Tao J, Han Z, Ju X, Gu M, Tan R, Li X. Association between a TLR2 gene polymorphism (rs3804099) and proteinuria in kidney transplantation recipients. Front Genet. 2022;21(12):798001.","journal-title":"Front Genet"},{"issue":"4","key":"9592_CR19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nrmicro2321","volume":"8","author":"CV Harding","year":"2010","unstructured":"Harding CV, Boom WH. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat Rev Microbiol. 2010;8(4):296\u2013307.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"9592_CR20","first-page":"496","volume":"18","author":"G Vilahur","year":"2014","unstructured":"Vilahur G, Badimon L. Ischemia\/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor. Front Physiol. 2014;18(5):496.","journal-title":"Front Physiol"},{"issue":"12","key":"9592_CR21","doi-asserted-by":"publisher","first-page":"BSR20191698","DOI":"10.1042\/BSR20191698","volume":"39","author":"SL Gao","year":"2019","unstructured":"Gao SL, Chen YD, Yue C, Chen J, Zhang LF, Wang SM, Zuo L. -196 to -174del, rs4696480, rs3804099 polymorphisms of Toll-like receptor 2 gene impact the susceptibility of cancers: evidence from 37053 subjects. Biosci Rep. 2019;39(12):BSR20191698.","journal-title":"Biosci Rep"},{"issue":"11","key":"9592_CR22","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.2147\/OTT.S168478","volume":"14","author":"A Semlali","year":"2018","unstructured":"Semlali A, Parine NR, Al-Numair NS, Almutairi M, Hawsawi YM, Amri AA, Aljebreen AM, Arafah M, Almadi MA, Azzam NA, Alharbi O, Alanazi MS. Potential role of Toll-like receptor 2 expression and polymorphisms in colon cancer susceptibility in the Saudi Arabian population. Onco Targets Ther. 2018;14(11):8127\u201341.","journal-title":"Onco Targets Ther"},{"issue":"6","key":"9592_CR23","first-page":"1573","volume":"5","author":"CW Mai","year":"2013","unstructured":"Mai CW, Kang YB, Pichika MR. Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers. Onco Targets Ther. 2013;5(6):1573\u201387.","journal-title":"Onco Targets Ther"},{"issue":"42","key":"9592_CR24","doi-asserted-by":"publisher","first-page":"e31247","DOI":"10.1097\/MD.0000000000031247","volume":"101","author":"Q Xiao","year":"2022","unstructured":"Xiao Q, Chen J, Zeng S, Cai H, Zhu G. An updated systematic review of the association between the TLR4 polymorphism rs4986790 and cancers risk. Medicine (Baltimore). 2022;101(42):e31247.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"9592_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12979-023-00383-3","volume":"20","author":"HJ Kim","year":"2023","unstructured":"Kim HJ, Kim H, Lee JH, Hwangbo C. Toll-like receptor 4 (TLR4): new insight immune and aging. Immun Ageing. 2023;20(1):67.","journal-title":"Immun Ageing"},{"issue":"1","key":"9592_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1756-9966-29-92","volume":"29","author":"H Yang","year":"2010","unstructured":"Yang H, Zhou H, Feng P, Zhou X, Wen H, Xie X, Shen H, Zhu X. Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion. J Exp Clin Cancer Res. 2010;29(1):92.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"9592_CR27","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3892\/ol.2021.13047","volume":"22","author":"L Li","year":"2021","unstructured":"Li L, Zhou Z, Mai K, Li P, Wang Z, Wang Y, Cao Y, Ma X, Zhang T, Wang D. Protein overexpression of toll-like receptor 4 and myeloid differentiation factor 88 in oral squamous cell carcinoma and clinical significance. Oncol Lett. 2021;22(5):786.","journal-title":"Oncol Lett"},{"issue":"2","key":"9592_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1600-0897.2006.00441.x","volume":"57","author":"R Chen","year":"2007","unstructured":"Chen R, Alvero AB, Silasi DA, Mor G. Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway. Am J Reprod Immunol. 2007;57(2):93\u2013107.","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"9592_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13058-015-0640-x","volume":"17","author":"M Mehmeti","year":"2015","unstructured":"Mehmeti M, Allaoui R, Bergenfelz C, Saal LH, Ethier SP, Johansson ME, Jirstr\u00f6m K, Leandersson K. Expression of functional toll like receptor 4 in estrogen receptor\/progesterone receptor-negative breast cancer. Breast Cancer Res. 2015;17(1):130.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"9592_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/OTT.S106024","volume":"16","author":"A Semlali","year":"2016","unstructured":"Semlali A, Parine NR, Al Amri A, Azzi A, Arafah M, Kohailan M, Shaik JP, Almadi MA, Aljebreen AM, Alharbi O, Ali Azzam N, Rouabhia M, Alanazi MS. Association between TLR-9 polymorphisms and colon cancer susceptibility in Saudi Arabian female patients. Onco Targets Ther. 2016;16(10):1\u201311.","journal-title":"Onco Targets Ther"},{"key":"9592_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43046-020-00027-3","volume":"32","author":"WM Al-Kahiry","year":"2020","unstructured":"Al-Kahiry WM, Dammag EA, Abdelsalam HS, Fadlallah HK, Owais MS. Toll-like receptor 9 negatively related to clinical outcome of AML patients. J Egypt Natl Canc Inst. 2020;32:1\u20137.","journal-title":"J Egypt Natl Canc Inst"},{"issue":"3","key":"9592_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/jpm12030409","volume":"12","author":"C Banescu","year":"2022","unstructured":"Banescu C, Tripon F, Bojan AS, Trifa AP, Muntean C, Crauciuc GA, Boglis A, Candea M, Lazar E, Jimbu L, Iancu M. Association of TLR4 Rs4986791 polymorphism and TLR9 haplotypes with acute myeloid leukemia susceptibility: a case-control study of adult patients. J Pers Med. 2022;12(3):409.","journal-title":"J Pers Med"},{"issue":"1","key":"9592_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.arcmed.2012.10.008","volume":"44","author":"V Singh","year":"2013","unstructured":"Singh V, Srivastava N, Kapoor R, Mittal RD. Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in a case-control study with bladder cancer susceptibility in a North Indian population. Arch Med Res. 2013;44(1):54\u201361.","journal-title":"Arch Med Res"},{"issue":"7","key":"9592_CR34","doi-asserted-by":"publisher","first-page":"7263","DOI":"10.1007\/s11033-012-1556-5","volume":"39","author":"RK Mandal","year":"2012","unstructured":"Mandal RK, George GP, Mittal RD. Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population. Mol Biol Rep. 2012;39(7):7263\u20139.","journal-title":"Mol Biol Rep"},{"issue":"6","key":"9592_CR35","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/leu.2011.341","volume":"26","author":"KG Miedema","year":"2012","unstructured":"Miedema KG, Tissing WJ, Te Poele EM, Kamps WA, Alizadeh BZ, Kerkhof M, de Jongste JC, Smit HA, de Pagter AP, Bierings M, Boezen HM, Postma DS, de Bont ES, Koppelman GH. Polymorphisms in the TLR6 gene associated with the inverse association between childhood acute lymphoblastic leukemia and atopic disease. Leukemia. 2012;26(6):1203\u201310.","journal-title":"Leukemia"},{"issue":"5","key":"9592_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2174\/1389202922666210921101728","volume":"22","author":"R Kumar","year":"2021","unstructured":"Kumar R, Rai AK, Phukan MM, Hussain A, Borah D, Gogoi B, Chakraborty P, Buragohain AK. Accumulating impact of smoking and co-morbidities on severity and mortality of COVID-19 infection: a systematic review and meta-analysis. Curr Genom. 2021;22(5):339\u201352.","journal-title":"Curr Genom"},{"key":"9592_CR37","doi-asserted-by":"publisher","first-page":"1280051","DOI":"10.3389\/fgene.2023.1280051","volume":"14","author":"A Al Othaim","year":"2023","unstructured":"Al Othaim A, Al-Hawary SIS, Alsaab HO, et al. Common variants in toll-like receptor family genes and risk of gastric cancer: a systematic review and meta-analysis. Front Genet. 2023;14:1280051.","journal-title":"Front Genet"},{"issue":"12","key":"9592_CR38","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1158\/1055-9965.EPI-11-0702","volume":"20","author":"HM Zeng","year":"2011","unstructured":"Zeng HM, Pan KF, Zhang Y, et al. Genetic variants of toll-like receptor 2 and 5, helicobacter pylori infection, and risk of gastric cancer and its precursors in a chinese population. Cancer Epidemiol Biomarkers Prev. 2011;20(12):2594\u2013602.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"9592_CR39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4168\/aair.2015.7.2.130","volume":"7","author":"K Tizaoui","year":"2015","unstructured":"Tizaoui K, Kaabachi W, Hamzaoui K, Hamzaoui A. Association of single nucleotide polymorphisms in toll-like receptor genes with asthma risk: a systematic review and meta-analysis. Allergy Asthma Immunol Res. 2015;7(2):130\u201340.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"8","key":"9592_CR40","doi-asserted-by":"publisher","first-page":"e71785","DOI":"10.1371\/journal.pone.0071785","volume":"8","author":"L Zhang","year":"2013","unstructured":"Zhang L, Qin H, Guan X, Zhang K, Liu Z. The TLR9 gene polymorphisms and the risk of cancer: evidence from a meta-analysis. PLoS One. 2013;8(8):e71785.","journal-title":"PLoS One"},{"issue":"1","key":"9592_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/25785826.2022.2132683","volume":"46","author":"B Zhou","year":"2023","unstructured":"Zhou B, Liang S, Shang S, Li L. Association of TLR2 and TLR9 gene polymorphisms with atopic dermatitis: a systematic review and meta-analysis with trial sequential analysis. Immunol Med. 2023;46(1):32\u201344.","journal-title":"Immunol Med"},{"issue":"4","key":"9592_CR42","doi-asserted-by":"publisher","first-page":"101985","DOI":"10.1016\/j.jksus.2022.101985","volume":"34","author":"FM AlKhulaifi","year":"2022","unstructured":"AlKhulaifi FM, Alkhuriji A, Mansour L, Al-jurayyan A, Al-Mulhim NM, Tashkandy YA, Aldossari GS, Alomar S. Association between toll-like receptor 4 polymorphism and acute lymphoblastic leukemia susceptibility in Saudi Arabian patients. J King Saud Univ Sci. 2022;34(4):101985.","journal-title":"J King Saud Univ Sci"},{"issue":"12","key":"9592_CR43","first-page":"3245","volume":"18","author":"YB Ali","year":"2017","unstructured":"Ali YB, Foad RM, Abdel-Wahed E. Lack of associations between TLR9 and MYD88 gene polymorphisms and risk of chronic lymphocytic leukemia. Asian Pac J Cancer Prev. 2017;18(12):3245\u201350.","journal-title":"Asian Pac J Cancer Prev"},{"key":"9592_CR44","doi-asserted-by":"crossref","unstructured":"Qu H, et al. Toll-like receptor 2 polymorphisms impose considerable impacts on acute myelocytic leukemi occurrence. 2020.","DOI":"10.21203\/rs.3.rs-47890\/v1"},{"issue":"1","key":"9592_CR45","doi-asserted-by":"publisher","first-page":"15159","DOI":"10.1038\/s41598-022-19130-7","volume":"12","author":"LA Xabregas","year":"2022","unstructured":"Xabregas LA, Hanna FSA, Magalh\u00e3es-Gama F, Souza GL, Pereira DS, de Lima AB, Toro DM, Santiago MRR, da Motta Passos LN, Tarrag\u00f4 AM, Malheiro A, Costa AG. Association of Toll-like receptors polymorphisms with the risk of acute lymphoblastic leukemia in the Brazilian Amazon. Sci Rep. 2022;12(1):15159.","journal-title":"Sci Rep"},{"issue":"2","key":"9592_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/iji.12255","volume":"43","author":"J Rybka","year":"2016","unstructured":"Rybka J, G\u0119bura K, Wrobel T, Wysocza\u0144ska B, Stefanko E, Kuliczkowski K, Bogunia-Kubik K. Variations in genes involved in regulation of the nuclear factor\u2013\u03baB pathway and the risk of acute myeloid leukaemia. Int J Immunogenet. 2016;43(2):101\u20136.","journal-title":"Int J Immunogenet"},{"issue":"59","key":"9592_CR47","doi-asserted-by":"publisher","first-page":"100593","DOI":"10.18632\/oncotarget.21543","volume":"8","author":"L Ding","year":"2017","unstructured":"Ding L, Jiang Li G, Shen J, Du J, Lu X, Xiong X. Comprehensive assessment of association between TLR4 gene polymorphisms and cancer risk: a systematic meta-analysis. Oncotarget. 2017;8(59):100593\u2013602.","journal-title":"Oncotarget"},{"issue":"12","key":"9592_CR48","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1089\/gtmb.2013.0246","volume":"17","author":"XQ Wang","year":"2013","unstructured":"Wang XQ, Liu L, Liu Y, Zhang K. TLR-2 gene polymorphisms and susceptibility to cancer: evidence from meta-analysis. Genet Test Mol Biomarkers. 2013;17(12):864\u201372.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"19","key":"9592_CR49","doi-asserted-by":"publisher","first-page":"8279","DOI":"10.7314\/APJCP.2014.15.19.8279","volume":"15","author":"GX Wan","year":"2014","unstructured":"Wan GX, Cao YW, Li WQ, Li YC, Zhang WJ, Li F. Associations between TLR9 polymorphisms and cancer risk: evidence from an updated meta-analysis of 25,685 subjects. Asian Pac J Cancer Prev. 2014;15(19):8279\u201385.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"7","key":"9592_CR50","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1182\/blood-2004-02-0557","volume":"104","author":"CF Skibola","year":"2004","unstructured":"Skibola CF, Forrest MS, Copped\u00e9 F, Agana L, Hubbard A, Smith MT, Bracci PM, Holly EA. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood. 2004;104(7):2155\u201362.","journal-title":"Blood"},{"issue":"11","key":"9592_CR51","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/jhg.2009.90","volume":"54","author":"V Mollaki","year":"2009","unstructured":"Mollaki V, Georgiadis T, Tassidou A, Ioannou M, Daniil Z, Koutsokera A, Papathanassiou AA, Zintzaras E, Vassilopoulos G. Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin\u2019s lymphoma: a candidate\u2013gene association study. J Hum Genet. 2009;54(11):655\u20139.","journal-title":"J Hum Genet"},{"issue":"9","key":"9592_CR52","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.3390\/ijms25095037","volume":"25","author":"YH Chen","year":"2024","unstructured":"Chen YH, Wu KH, Wu HP. Unraveling the complexities of toll-like receptors: from molecular mechanisms to clinical applications. Int J Mol Sci. 2024;25(9):5037.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"9592_CR53","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1038\/cddis.2012.60","volume":"3","author":"J Noack","year":"2012","unstructured":"Noack J, Jordi M, Zauner L, Alessi D, Burch A, Tinguely M, Hersberger M, Bernasconi M, Nadal D. TLR9 agonists induced cell death in Burkitt\u2019s lymphoma cells is variable and influenced by TLR9 polymorphism. Cell Death Dis. 2012;3(6):e323.","journal-title":"Cell Death Dis"},{"issue":"9","key":"9592_CR54","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1089\/jir.2012.0140","volume":"33","author":"AE Medvedev","year":"2013","unstructured":"Medvedev AE. Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer. J Interferon Cytokine Res. 2013;33(9):467\u201384.","journal-title":"J Interferon Cytokine Res"},{"key":"9592_CR55","doi-asserted-by":"publisher","first-page":"105149","DOI":"10.1016\/j.micpath.2021.105149","volume":"159","author":"N Pandey","year":"2021","unstructured":"Pandey N, Chauhan A, Raithatha N, Patel P, Khandelwal R, Desai A, Choxi Y, Kapadia R, Jain N. Influence of TLR4 and TLR9 polymorphisms and haplotypes on multiple hrHPV infections and HPV16 copy number in cervical cancer and cervicitis. Microb Pathog. 2021;159:105149.","journal-title":"Microb Pathog"},{"issue":"1","key":"9592_CR56","doi-asserted-by":"publisher","first-page":"9729","DOI":"10.1038\/s41598-019-46077-z","volume":"9","author":"NO Pandey","year":"2019","unstructured":"Pandey NO, Chauhan AV, Raithatha NS, Patel PK, Khandelwal R, Desai AN, Choxi Y, Kapadia RS, Jain ND. Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility. Sci Rep. 2019;9(1):9729.","journal-title":"Sci Rep"},{"issue":"4","key":"9592_CR57","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783\u2013801.","journal-title":"Cell"},{"key":"9592_CR58","doi-asserted-by":"publisher","first-page":"812774","DOI":"10.3389\/fimmu.2022.812774","volume":"13","author":"T Duan","year":"2022","unstructured":"Duan T, Du Y, Xing C, Wang HY, Wang RF. Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol. 2022;13:812774.","journal-title":"Front Immunol"},{"issue":"1","key":"9592_CR59","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1182\/asheducation-2016.1.293","volume":"2016","author":"RB McGee","year":"2016","unstructured":"McGee RB, Nichols KE. Introduction to cancer genetic susceptibility syndromes. Hematol Am Soc Hematol Educ Program. 2016;2016(1):293\u2013301.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"12","key":"9592_CR60","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1002\/ijc.26314","volume":"2980","author":"ML Slattery","year":"2012","unstructured":"Slattery ML, Herrick JS, Bondurant KL, Wolff RK. Toll-like receptor genes and their association with colon and rectal cancer development and prognosis. Int J Cancer. 2012;2980(12):2974\u201380.","journal-title":"Int J Cancer"},{"issue":"3","key":"9592_CR61","first-page":"79","volume":"18","author":"L Oliveira-Nascimento","year":"2012","unstructured":"Oliveira-Nascimento L, Massari P, Wetzler LM. The Role of TLR2 in Infection and Immunity. Front Immunol. 2012;18(3):79.","journal-title":"Front Immunol"},{"issue":"5","key":"9592_CR62","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","volume":"112","author":"TW LeBien","year":"2008","unstructured":"LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood. 2008;112(5):1570\u201380.","journal-title":"Blood"},{"issue":"10","key":"9592_CR63","doi-asserted-by":"publisher","first-page":"e109605","DOI":"10.1371\/journal.pone.0109605","volume":"9","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Wang C, Wang X, Wu X, Zhu Z, Liu B, Su L. Association between TLR4 (+896A\/G and +1196C\/T) polymorphisms and gastric cancer risk: an updated meta-analysis. PLoS One. 2014;9(10):e109605.","journal-title":"PLoS One"},{"issue":"5","key":"9592_CR64","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1080\/08820139.2020.1716787","volume":"49","author":"M Moaaz","year":"2020","unstructured":"Moaaz M, Youssry S, Moaz A, Abdelrahman M. Study of toll-like receptor 4 gene polymorphisms in colorectal cancer: correlation with clinicopathological features. Immunol Investig. 2020;49(5):571\u201384.","journal-title":"Immunol Investig"},{"issue":"1","key":"9592_CR65","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4103\/0970-1591.109982","volume":"29","author":"A Priyadarshini","year":"2013","unstructured":"Priyadarshini A, Chakraborti A, Mandal AK, Singh SK. Asp299Gly and Thr399Ile polymorphism of TLR-4 gene in patients with prostate cancer from North India. Indian J Urol. 2013;29(1):37\u201341.","journal-title":"Indian J Urol"},{"issue":"9","key":"9592_CR66","doi-asserted-by":"publisher","first-page":"e794","DOI":"10.1038\/cddis.2013.334","volume":"4","author":"X Yuan","year":"2013","unstructured":"Yuan X, Zhou Y, Wang W, Li J, Xie G, Zhao Y, Xu D, Shen L. Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production. Cell Death Dis. 2013;4(9):e794.","journal-title":"Cell Death Dis"},{"issue":"3","key":"9592_CR67","first-page":"172","volume":"13","author":"M Delkhah","year":"2023","unstructured":"Delkhah M, Arasteh J, Koochakzadeh L, Rostami S. Evaluation of association of rs4986790 and rs4986791 single-nucleotide polymorphisms in TLR4 with febrile neutropenia in childhood acute lymphoblastic leukemia. Iran J Pediatr Hematol Oncol. 2023;13(3):172\u201381.","journal-title":"Iran J Pediatr Hematol Oncol"},{"key":"9592_CR68","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1128\/IAI.01226-09","volume":"78","author":"MT Ng","year":"2010","unstructured":"Ng MT, Van\u2019t Hof R, Crockett JC, Hope ME, Berry S. Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9\u20131237T\/C polymorphism is associated with Helicobacter pylori-induced gastric disease. Infect Immun. 2010;78:1345\u201352.","journal-title":"Infect Immun"},{"issue":"1","key":"9592_CR69","doi-asserted-by":"publisher","first-page":"57","DOI":"10.7150\/jca.37033","volume":"11","author":"J Qian","year":"2020","unstructured":"Qian J, Meng H, Lv B, Wang J, Lu Y, Su L, Zhao S, Li W. High expression levels of TLR9 and PD-L1 indicates a poor prognosis in patients with angioimmunoblastic T-cell lymphoma: a retrospective study of 88 cases in a single center. J Cancer. 2020;11(1):57\u201368.","journal-title":"J Cancer"},{"key":"9592_CR70","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1089\/dna.2011.1427","volume":"31","author":"X Chen","year":"2012","unstructured":"Chen X, Wang S, Liu L, Chen Z, Qiang F. A genetic variant in the promoter region of Toll-like receptor 9 and cervical cancer susceptibility. DNA Cell Biol. 2012;31:766\u201371.","journal-title":"DNA Cell Biol"},{"key":"9592_CR71","doi-asserted-by":"publisher","first-page":"8425","DOI":"10.1007\/s11033-012-1695-8","volume":"39","author":"A Roszak","year":"2012","unstructured":"Roszak A, Lianeri M, Sowinska A, Jagodzinski PP. Involvement of toll-like receptor 9 polymorphism in cervical cancer development. Mol Biol Rep. 2012;39:8425\u201330.","journal-title":"Mol Biol Rep"},{"key":"9592_CR72","unstructured":"Zeng HM, Pan KF, Zhang Y, Zhang L, Ma JL, Zhou T, Su HJ, Li WQ, Li JY, You WC. The correlation between polymorphisms of Toll-like receptor 2 and Toll-like receptor 9 and susceptibility to gastric cancer. 2011;45(7):588\u201392."},{"key":"9592_CR73","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/sj.gene.6364337","volume":"7","author":"A Nieters","year":"2006","unstructured":"Nieters A, Beckmann L, Deeg E, Becker N. Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk. Genes Immun. 2006;7:615\u201324.","journal-title":"Genes Immun"},{"issue":"5","key":"9592_CR74","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.4049\/jimmunol.1600757","volume":"198","author":"J Pohar","year":"2017","unstructured":"Pohar J, Yamamoto C, Fukui R, Cajnko MM, Miyake K, Jerala R, Ben\u010dina M. Selectivity of human TLR9 for double CpG motifs and implications for the recognition of genomic DNA. J Immunol. 2017;198(5):2093\u2013104.","journal-title":"J Immunol"},{"issue":"3","key":"9592_CR75","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.transci.2019.04.023","volume":"58","author":"A Alshalani","year":"2019","unstructured":"Alshalani A, Li W, Juffermans NP, Seghatchian J, Acker JP. Biological mechanisms implicated in adverse outcomes of sex mismatched transfusions. Transfus Apher Sci. 2019;58(3):351\u20136.","journal-title":"Transfus Apher Sci"},{"key":"9592_CR76","doi-asserted-by":"publisher","first-page":"705197","DOI":"10.3389\/fimmu.2021.705197","volume":"21","author":"S Mashhouri","year":"2021","unstructured":"Mashhouri S, Koleva P, Huynh M, Okoye I, Shahbaz S, Elahi S. Sex matters: physiological abundance of immuno-regulatory CD71+ erythroid cells impair immunity in females. Front Immunol. 2021;21:705197.","journal-title":"Front Immunol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09592-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09592-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09592-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:02:42Z","timestamp":1770192162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09592-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9592"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09592-y","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"7 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The systematic review and meta-analysis in this work was carried out in accordance with PRISMA and MOOSE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"35"}}